(Correction: This story corrects several figures from a previously released story.)
Profound Medical Corp. (PROF) released its third quarter financial results on Thursday, reporting a net loss that narrowed compared to the same quarter a year ago.
The commercial-stage medical device company said its third quarter net loss was approximately $8.0 million, or $0.26 per common share, a 15% improvement from a net loss of approximately $9.4 million, or $0.38 per common share, in the three months ended September 30, 2024.
Profound Medical said its revenue for the period soared 87% year-over-year to a record $5.29 million in the third quarter of 2025 from $2.83 million a year ago.
Profound Medical Corp. results at a glance (GAAP) :
-Net loss: $7.97 Mln vs. $9.36 Mln last year.-Loss per share: $0.26 vs. $0.38 last year.-Revenue: $5.29 Mln vs. $2.83 Mln last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.